RTTNews | Jan 6, 2022 10:59AM EST

10:59 Thursday, January 6, 2022 (RTTNews.com) - Curis, Inc. (CRIS) shares are declining more than 28 percent on Thursday morning trade after the company updated phase 1 /2 study of CA - 4948 monotherapy in targeted patients with relapsed or refractory acute myeloid leukemia or AML and myelodysplastic syndrome or MDS. The shares have been declining since January 4th. Currently, shares are at $3.46, up 28.36 percent from the previous close of $4.83 on a volume of 4,130,703. The shares have traded in a range of $3.32-$4.80 on average volume of 1,566,961 for the last 52 weeks.

Read the original article on RTTNews ( https://www.rttnews.com/3253287/curis-shares-down-27.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2022 RTTNews.com All Rights Reserved